Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPermnt Tsb 30 Regulatory News (73HR)

Share Price Information for Permnt Tsb 30 (73HR)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
73HR Live PriceLast checked at - London Stock Exchange

Intraday Permnt Tsb 30 Share Chart

Trading Statement

11 May 2016 07:00

RNS Number : 8516X
Permanent TSB Group Holdings PLC
11 May 2016
 

EMBARGO 07:00 11 May 2016

PERMANENT TSB GROUP HOLDINGS PLC

TRADING UPDATE FOR THE FIRST QUARTER ENDED 31 MARCH 2016

Permanent TSB Group Holdings plc (the "Group") today reports its trading update.

 

The Group continues to trade in line with expectations and has been profitable for Q1. However, there are challenges ahead; in particular, increasing external regulatory costs, the continued low interest rate environment and the requirement to hold the residual UK mortgage book for longer than originally anticipated. We are satisfied with performance to date and will continue to manage effectively the controllable costs and grow the business.

 

Key Points:

 

· The Group was profitable (on a pre- and post-tax basis) in Q1 and traded in line with Management expectations

· The Group NIM (excluding ELG fees) increased to 1.47% (Core Bank: 1.75%). The Group remains on track to reach its medium term target NIM of 1.70%

· The Group Cost of Funds reduced to 0.77%; however, the outlook is for this to increase over 2016 due to the requirement to hold the residual UK mortgage book for longer and a continued reduction in ECB funding which reflects the Group's return to a more normalised market funding structure.

· The Group Cost Income Ratio continues to trend downwards; however, the outlook is challenging with particular regard to the (yet unknown) quantum of Regulatory Costs

· The Group Underlying Cost of Risk continues to be in line with expectations and is on-track to stabilise at 40bps or less

· ROI Home Loan and Buy-To-Let NPLs reduced further by €0.2bn

· The Group Fully Loaded CET1 ratio increased to 15.4%

· The Group's new mortgage lending grew by 4% to end April on a year-on-year (yoy) basis, although this is still constrained by limited growth in the mortgage market

 

Core Bank: Summary

 

The Core Bank's NIM (excluding ELG fees) improved to 1.75% for Q1 2016 driven primarily by the continued reduction in Cost of Funds.

 

The Core Bank introduced a new mortgage proposition, supported by a new brand campaign, in the first quarter. Although these initiatives are at an early stage, the response from customers is positive, resulting in a 10% increase in mortgage applications and a 4% increase in mortgage drawdowns to end April on a yoy basis. However, growth in the mortgage market in Ireland continues to be subdued primarily as a result of the constrained supply of housing. This is evidenced by the fall in total market mortgage approvals by c.14% in Q1 on a yoy basis.

 

Group: Operating Performance

 

NIM (excluding ELG fees) increased to 1.47% for Q1 2016 (Q4 2015 NIM - 1.30%) primarily due to the ongoing reduction in the Cost of Funds.

 

As highlighted at the issuance of the 2015 Annual Results in March, the Group continues to explore all options with regard to the deleveraging of its residual UK mortgage book.

 

The Group is in the process of evaluating the impact of funding the UK portfolio for a longer period than previously planned. In addition, the Group intends to strengthen further its balance sheet through increased wholesale market funding, thereby reducing its reliance on ECB funding to a lower level than previously guided, representing a return to a more normalised funding structure.

 

As a result of the above factors, the Group expects the full year NIM to be lower than that of the first quarter. However, the Group remains on track to reach its medium term target NIM of 1.70%.

 

The Group recognises the need for continuous investment across areas of the business including: improving customer experience; strengthening risk management, governance and controls functions; and, emerging mandatory requirements including various new projects such as the implementation of IFRS 9. At the same time, the Group remains focused on tight cost control and reiterates its previous guidance of an underlying operating cost base of approximately €270 million by 2018 (excluding emerging regulatory-related costs).

 

The Group continues to face a significant regulatory cost challenge arising from required contributions to the Single Resolution Fund and the Deposit Guarantee Scheme. Although the exact quantum of all of these costs remains unknown at this point in time, we expect that these costs will add between €20-€35 million to our cost base in 2016, as highlighted at the 2015 Annual Results in March.

 

Group: Funding

 

Total customer deposits continue to represent the major source of funding for the Group. In particular, Retail Deposits amounted to 55% of Total Funding. The Group continues to optimise its funding mix and is currently examining the potential for Senior Unsecured and Secured issuances later this year.

 

The Loan to Deposits Ratio (LDR) remained elevated at 132% at the end of Q1, mainly due to the delay in the sale of the Non-Core UK assets. The Group expects the LDR to normalise once the sale of these assets is concluded.

 

Group: Asset Quality

 

Asset quality trends continue to be satisfactory and are in line with our expectations. ROI Home Loan and Buy-To-Let NPLs reduced further by €0.2bn in Q1. The underlying impairment performance reflects this.

 

The Group continues to monitor closely the value of underlying collateral, as measured by the CSO Residential Property Price Index, and notes that National Residential Property Prices are up 7.4% in the year to March 2016.

 

The Group will continue to review its impairment provision modelling assumptions and parameters as part of the statutory reporting processes later this year.

 

Group: Capital & Risk Weighted Assets (RWAs)

 

At the end of Q1, the Group's Transitional and Fully Loaded CET1 ratios were 17.3% and 15.4% respectively compared to 17.1% and 15.0% at December 2015. The increase is primarily attributable to improved performance in the period. However, RWAs remain elevated mainly due to the continued retention of the Non-Core UK assets.

 

The Group remains cautious of the impact of both harmonised risk weights on its internal models and the ongoing review of risk weights of sovereign exposures.

 

Non-Core

The residual UK mortgage book of £2.4 billion remains non-core to the Group and we continue to explore options to deleverage these assets. As highlighted previously, market dynamics have changed considerably in the UK mortgage market; in particular, the risk of Britain exiting the EU, which is to be decided at the referendum on 23 June, coupled with a competitive market for similar portfolios.

 

Group: Outlook

 

The Group set out its Medium Term Targets as part of the Capital Raise in early 2015 and has made good progress in working towards its strategic objectives by growing the NIM, managing operating costs that are within the Group's control, continuing to manage NPLs, and maintaining a robust capital base.

 

However, the Group's financial performance will be impacted by external factors such as increasing regulatory costs, a more modest growth outlook in the mortgage market given the ongoing constrained supply of housing in Ireland, and a sustained low interest rate environment, which has impacted bank earnings across Europe.

 

These factors, coupled with uncertainty around the timing of the sale of residual UK assets, mean that the Group may not generate a Return On Equity of c.10% by 2018 as previously guided. However, the Group continues to make progress towards returning to sustainable profitability and maximising relative returns for shareholders over the medium term.

 

Ends

For further information, please contact:

 

Patricia Carroll

Interim Group Chief Financial Officer

patricia.carroll@permanenttsb.ie

+353 1 669 5354

Rajesh ManirajanHead of Investor Relationsrajesh.manirajan@permanenttsb.ie+353 1 669 5622

Ray GordonGordon MRMptsb@gordonmrm.ie+353 87 241 7373

 

Note on forward-looking information:

This Announcement contains forward-looking statements, which are subject to risks and uncertainties because they relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Group or the industry in which it operates, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements referred to in this paragraph speak only as at the date of this Announcement. The Group undertakes no obligation to release publicly any revision or updates to these forward-looking statements to reflect future events, circumstances, unanticipated events, new information or otherwise except as required by law or by any appropriate regulatory authority.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFWFWSFMSEEI
Date   Source Headline
29th Aug 20187:00 amRNS2018 Half-Year Results Commentary
31st Jul 20182:15 pmRNSSale of Non Performing Loan Portfolio
27th Jul 20187:00 amRNSDirectorate Change
24th Jul 201811:00 amRNSDirectorate Change
16th May 20187:00 amRNSTrading Statement
4th May 20184:29 pmRNS?5,000,000,000 Euro Note Programme
6th Apr 20183:00 pmRNSCourt approval for cancellation of deferred shares
29th Mar 201811:34 amRNSAnnual Financial Report
14th Mar 20187:00 amRNS2017 Annual Results Commentary
14th Mar 20187:00 amRNSAnnual Financial Report
21st Dec 20177:00 amRNS2017 Supervisory Review and Evaluation Process
8th Nov 20177:00 amRNSTrading Statement
27th Jul 201710:00 amRNSHalf-year Report
26th Jul 20177:00 amRNS2017 Half-Year Results Commentary
26th Jul 20177:00 amRNSHalf-year Report
10th May 20174:45 pmRNSConfirmation of Director Appointment
10th May 20177:00 amRNSTrading Update
12th Apr 20173:29 pmRNSRemoval of Notes - ISIN XS0214072752
3rd Apr 201710:00 amRNSAnnual Financial Report
31st Mar 201711:00 amRNSChairman Appointment Update/New Company Secretary
8th Mar 20177:00 amRNSAnnual Financial Report Commentary
7th Mar 20172:00 pmRNSAppointment of Chairman
21st Dec 20163:00 pmRNSSupervisory Review & Evaluation Process Update
13th Dec 20162:30 pmRNS2016 Supervisory Review and Evaluation Process
10th Nov 20167:00 amRNSTrading Statement
27th Oct 20167:00 amRNSSale Agreed for Non-Core UK Assets
26th Oct 20163:00 pmRNSDirectorate Change (Chairman)
27th Sep 201610:00 amRNSDirectorate Change
29th Jul 20164:00 pmRNSTypographical Error in Half Year Report
27th Jul 20163:00 pmRNSHalf-year Report
27th Jul 20167:00 amRNSHalf-Year Results Commentary
11th May 20167:00 amRNSTrading Statement
19th Apr 201611:15 amRNSAppointment of Chief Risk Officer
16th Mar 20164:30 pmRNSAnnual Financial Report
9th Mar 20167:00 amRNSAnnual Financial Report
9th Mar 20167:00 amRNSAnnual Results Commentary
10th Nov 20157:00 amRNSTrading Statement
18th Aug 20153:00 pmRNSSenior Management Changes
29th Jul 20153:00 pmRNSHalf Yearly Report
28th Jul 20158:30 amRNSPreliminary 2015 Half Year Results
17th Jul 20153:00 pmRNSSenior Management Change
1st Jul 20157:00 amRNSStandard Variable Rate Mortgage Pricing Update
7th May 201510:11 amRNSCancellation of Notes
27th Apr 20155:51 pmRNSAnnouncement of Open Offer Terms and Timetable
27th Apr 20155:49 pmRNSPlacing of Shares - Announcement of Offer Price
27th Apr 201511:31 amRNSPre-Stabilisation Notice - Perm TSB Perpetual
23rd Apr 20157:00 amRNSRepurchase Contingent Convertible Notes
14th Apr 20157:00 amRNSTrading Statement
14th Apr 20157:00 amRNSCapital Raising Update
9th Apr 20153:04 pmRNSApproval of pemanent tsb Restucturing Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.